1. Predicting Nasal High-Flow Treatment Success in Newborn Infants with Respiratory Distress Cared for in Nontertiary Hospitals
- Author
-
Megan McKimmie-Doherty, Gaston R.B. Arnolda, Adam G. Buckmaster, Louise S. Owen, Kate A. Hodgson, Ian M.R. Wright, Calum T. Roberts, Peter G. Davis, Brett J. Manley, Amy Tagliante Saracino, Bernice Mills, Rosalynn J. Pszczola, Haidee J. Murnane, Wei Qi Fan, Amanda J. Freeman, Gloria J. Pegler, Barbara Rischitelli, Isaac R. Marshall, Melissa Blake, Alice Y.W. Fang, Elizabeth L. Thomas, Nancy Yuen, Tracy Huang, Tracey L. Clark, Christine M. Monagle, Li Huang, Kim M. Dalziel, Jane Wardle, Ahmed Khan, Ashley N. Blood, Patrice Nolan, and Jann P. Foster
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Randomization ,medicine.medical_treatment ,Birth weight ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,030225 pediatrics ,Fraction of inspired oxygen ,Positive airway pressure ,medicine ,Cannula ,Humans ,Infant, Very Low Birth Weight ,030212 general & internal medicine ,Continuous positive airway pressure ,Respiratory Distress Syndrome, Newborn ,Noninvasive Ventilation ,Respiratory distress ,business.industry ,Australia ,Infant, Newborn ,Oxygen Inhalation Therapy ,Gestational age ,Pediatrics, Perinatology and Child Health ,Female ,business ,Infant, Premature - Abstract
Objective To evaluate demographic and clinical variables as predictors of nasal high-flow treatment success in newborn infants with respiratory distress cared for in Australian nontertiary special care nurseries. Study design A secondary analysis of the HUNTER trial, a multicenter, randomized controlled trial evaluating nasal high-flow as primary respiratory support for newborn infants with respiratory distress who were born ≥31 weeks of gestation and with birth weight ≥1200 g, and cared for in Australian nontertiary special care nurseries. Treatment success within 72 hours after randomization to nasal high-flow was determined using objective criteria. Univariable screening and multivariable analysis was used to determine predictors of nasal high-flow treatment success. Results Infants (n = 363) randomized to nasal high-flow in HUNTER were included in the analysis; the mean gestational age was 36.9 ± 2.7 weeks and birth weight 2928 ± 782 g. Of these infants, 290 (80%) experienced nasal high-flow treatment success. On multivariable analysis, nasal high-flow treatment success was predicted by higher gestational age and lower fraction of inspired oxygen immediately before randomization, but not strongly. The final model was found to have an area under the curve of 0.65, which after adjustment for optimism was found to be 0.63 (95% CI, 0.57-0.70). Conclusions Gestational age and supplemental oxygen requirement may be used to guide decisions regarding the most appropriate initial respiratory support for newborn infants in nontertiary special care nurseries. Further prospective research is required to better identify which infants are most likely to be successfully treated with nasal high-flow. Trial registration ACTRN12614001203640.
- Published
- 2020